… for patients is the collection of non-mobilised peripheral blood lymphocytes through leukapheresis,” he explains. CAR … growing interest for the treatment of various malignant diseases,” explains Professor Koehl. “With further …

… A, Snowden J, Kröger N, Mohty M, Gratwohl A; Infectious Diseases Working Party EBMT. Bone Marrow Transplant. 2019 Aug … Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Giebel S, Boumendil …

… in SCD, followed by Suhag Parikh (Atlanta, USA) on cord blood. Satya Yadav from India presented highly relevant data … The history and rebirth of gene therapy in non-malignant diseases. He showed the clinical pathway and nursing and how … Report of the Paediatric Diseases Working Party Educational Meeting on …

… She underwent haploidentical myeloablative peripheral blood HCT, with Busulphan/Fludarabine and PTCy/MMF/CsA … kidney transplantation for malignant or non-malignant diseases showed that renal failure was common and that … medications, chemotherapy, immunosuppressants and blood components, managing the central venous catheter and …

… on plasmacells, the presence of soluble BCMA in the blood and the use of anti BCMA CAR T cells in Multiple … cytokine levels after infusion but especially auto immune diseases. Patients with auto immune diseases are currently … only results in uniform CAR expression in human peripheral blood T cells, but also enhances T-cell potency, with edited …

… develop new drug products targeting different antigens and diseases, and compete with north-American or Chinese … off-the-shelf “CAR-NK Cells” manufactured from cord blood units, and targeting CD19 positive hematological … Data in one patient showed that CAR-T cells penetrated blood-testis barrier and eradicated leukemia cells in testis. …

… Transplantation. Session I: Stem cell therapy in metabolic diseases  chaired by Maria Ester Bernardo & Robert Wynn   … on the GOSH experience on metagenomic samples from CSF, blood and tissue samples.  Metagenomics can detect any … of ADA compared to retrovirus. Mobilized peripheral blood is better than bone marrow. Gene therapy resulted in …

… and management of haematological and oncological diseases. The multidisciplinary approach to patient care, … transplantation, as documented in the European Society for Blood and Marrow Transplantation (EBMT)’s database. Brexu-cel … predictive value of this functional read-out in lymphatic diseases, aiming to further understand and predict treatment …

… Group, serving as Chair and contributing to the Paediatric Diseases Working Party. I work as a paediatric oncology and … within their respective roles. I currently work with NHS Blood and Transplant within the Therapeutic Apheresis Service …

… targets for GvHD as well as for cancer and infectious diseases in patients undergoing allogeneic hematopoietic cell … therapy, recent findings and issues in the treatment of blood diseases and in hematopoietic cell transplantation as well. …